A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

ObjectiveHypertension is a leading global risk factor for disability and death. Irbesartan, a potent angiotensin II receptor blocker, requires continuous safety monitoring. We conducted a disproportionality analysis of irbesartan-related adverse drug events (ADEs) using the FDA’s FAERS and Japan’s J...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Liu, Zhiwei Cui, Chao Deng, Chao Yang, Tao Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Pharmacology
Subjects:
pharmacovigilance
disproportionality analysis
FAERS
JADER
irbesartan
adverse drug events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1485190/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1485190/full

Similar Items